DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Trengestone
Trengestone
Tkenbolone Acetate ATC: A14 (Trienbolone Acetate) Use: Anabolic
Pharmaceutical Appendix to the Tariff Schedule 2
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Wo 2008/127291 A2
(12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al
Stembook 2018.Pdf
Customs Tariff - Schedule
United States Patent (19) 11 4,244,949 Gupta 45) Jan
Council of Europe Committee of Ministers (Partial
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Composition and Methods for Transdermal Delivery Of
Customs Tariff - Schedule
Conjugated Equine Estrogen and Medroxyprogesterone Acetate Are Associated with Decreased Risk of Breast Cancer Relative to Bioidentical Hormone Therapy and Controls
Transdermal Device Containing
Pharmaabkommen A1 E
(12) United States Patent (10) Patent No.: US 8,414.914 B2 Bromley Et Al
Customs Tariff - Schedule Xxi - 1
Top View
(12) Patent Application Publication (10) Pub. No.: US 2002/0004065 A1 Kanios (43) Pub
Resolution Ap (77) 1
Harmonized Tariff Schedule of the United States (2006) (Rev
(12) Patent Application Publication (10) Pub. No.: US 2003/0027804 A1 Van Der Hoop (43) Pub
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Customs Tariff - Schedule Xxi - 1
(12) Patent Application Publication (10) Pub. No.: US 2003/0114430 A1 Macleod Et Al
WO 2U11/132171 Al
(12) United States Patent (10) Patent No.: US 7,387,623 B2 Macleod (45) Date of Patent: Jun
(12) Patent Application Publication (10) Pub. No.: US 2012/0058981 A1 Dudley Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmaceutical Appendix to the Tariff Schedule 2
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
Resolution Ap (2000) 1
Composition for Transdermal And/Or Transmucosal Administration of Active Compounds Which Ensures Adequate Therapeutic Levels
Schedule Clxxiii - European Union
WO 2017/072719 Al 4 May 2017 (04.05.2017) P O P C T